Global Transdermal Drug Patches Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Transdermal Drug Patches Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

According to APO Research, The global Transdermal Drug Patches market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Transdermal Drug Patches is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Transdermal Drug Patches is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Transdermal Drug Patches is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Transdermal Drug Patches is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Transdermal Drug Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal and IBSA Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Transdermal Drug Patches, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Transdermal Drug Patches, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Drug Patches, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Drug Patches sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal Drug Patches market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Transdermal Drug Patches sales, projected growth trends, production technology, application and end-user industry.

Transdermal Drug Patches segment by Company

Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Transdermal Drug Patches segment by Type

Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Transdermal Drug Patches segment by Application

Rx Channel
OTC Channel
Transdermal Drug Patches segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Drug Patches market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Drug Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Drug Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Transdermal Drug Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Transdermal Drug Patches Market Size, 2019 VS 2023 VS 2030
1.3 Global Transdermal Drug Patches Market Size Estimates and Forecasts (2019-2030)
1.4 Global Transdermal Drug Patches Sales Estimates and Forecasts (2019-2030)
1.5 Global Transdermal Drug Patches Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Transdermal Drug Patches Market Dynamics
2.1 Transdermal Drug Patches Industry Trends
2.2 Transdermal Drug Patches Industry Drivers
2.3 Transdermal Drug Patches Industry Opportunities and Challenges
2.4 Transdermal Drug Patches Industry Restraints
3 Transdermal Drug Patches Market by Manufacturers
3.1 Global Transdermal Drug Patches Revenue by Manufacturers (2019-2024)
3.2 Global Transdermal Drug Patches Sales by Manufacturers (2019-2024)
3.3 Global Transdermal Drug Patches Average Sales Price by Manufacturers (2019-2024)
3.4 Global Transdermal Drug Patches Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Transdermal Drug Patches Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Transdermal Drug Patches Manufacturers, Product Type & Application
3.7 Global Transdermal Drug Patches Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Transdermal Drug Patches Market CR5 and HHI
3.8.2 Global Top 5 and 10 Transdermal Drug Patches Players Market Share by Revenue in 2023
3.8.3 2023 Transdermal Drug Patches Tier 1, Tier 2, and Tier 3
4 Transdermal Drug Patches Market by Type
4.1 Transdermal Drug Patches Type Introduction
4.1.1 Methyl Salicylate-based Patch
4.1.2 Rivastigmine Transdermal Patch
4.1.3 Fentanyl Transdermal Patch
4.1.4 Lidocaine Patch
4.1.5 Diclofenac Patch
4.1.6 Nicotine Transdermal Patch
4.1.7 Others
4.2 Global Transdermal Drug Patches Sales by Type
4.2.1 Global Transdermal Drug Patches Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Transdermal Drug Patches Sales by Type (2019-2030)
4.2.3 Global Transdermal Drug Patches Sales Market Share by Type (2019-2030)
4.3 Global Transdermal Drug Patches Revenue by Type
4.3.1 Global Transdermal Drug Patches Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Transdermal Drug Patches Revenue by Type (2019-2030)
4.3.3 Global Transdermal Drug Patches Revenue Market Share by Type (2019-2030)
5 Transdermal Drug Patches Market by Application
5.1 Transdermal Drug Patches Application Introduction
5.1.1 Rx Channel
5.1.2 OTC Channel
5.2 Global Transdermal Drug Patches Sales by Application
5.2.1 Global Transdermal Drug Patches Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Transdermal Drug Patches Sales by Application (2019-2030)
5.2.3 Global Transdermal Drug Patches Sales Market Share by Application (2019-2030)
5.3 Global Transdermal Drug Patches Revenue by Application
5.3.1 Global Transdermal Drug Patches Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Transdermal Drug Patches Revenue by Application (2019-2030)
5.3.3 Global Transdermal Drug Patches Revenue Market Share by Application (2019-2030)
6 Global Transdermal Drug Patches Sales by Region
6.1 Global Transdermal Drug Patches Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Transdermal Drug Patches Sales by Region (2019-2030)
6.2.1 Global Transdermal Drug Patches Sales by Region (2019-2024)
6.2.2 Global Transdermal Drug Patches Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Transdermal Drug Patches Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Transdermal Drug Patches Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Transdermal Drug Patches Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Transdermal Drug Patches Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Transdermal Drug Patches Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Transdermal Drug Patches Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Transdermal Drug Patches Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Transdermal Drug Patches Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Transdermal Drug Patches Revenue by Region
7.1 Global Transdermal Drug Patches Revenue by Region
7.1.1 Global Transdermal Drug Patches Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Transdermal Drug Patches Revenue by Region (2019-2024)
7.1.3 Global Transdermal Drug Patches Revenue by Region (2025-2030)
7.1.4 Global Transdermal Drug Patches Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Transdermal Drug Patches Revenue (2019-2030)
7.2.2 North America Transdermal Drug Patches Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Transdermal Drug Patches Revenue (2019-2030)
7.3.2 Europe Transdermal Drug Patches Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Transdermal Drug Patches Revenue (2019-2030)
7.4.2 Asia-Pacific Transdermal Drug Patches Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Transdermal Drug Patches Revenue (2019-2030)
7.5.2 LAMEA Transdermal Drug Patches Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Hisamitsu Pharmaceutical
8.1.1 Hisamitsu Pharmaceutical Comapny Information
8.1.2 Hisamitsu Pharmaceutical Business Overview
8.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Portfolio
8.1.5 Hisamitsu Pharmaceutical Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Transdermal Drug Patches Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Novartis Transdermal Drug Patches Product Portfolio
8.3.5 Novartis Recent Developments
8.4 UCB Pharma
8.4.1 UCB Pharma Comapny Information
8.4.2 UCB Pharma Business Overview
8.4.3 UCB Pharma Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 UCB Pharma Transdermal Drug Patches Product Portfolio
8.4.5 UCB Pharma Recent Developments
8.5 Mylan
8.5.1 Mylan Comapny Information
8.5.2 Mylan Business Overview
8.5.3 Mylan Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Mylan Transdermal Drug Patches Product Portfolio
8.5.5 Mylan Recent Developments
8.6 Teva Pharmaceutical
8.6.1 Teva Pharmaceutical Comapny Information
8.6.2 Teva Pharmaceutical Business Overview
8.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Portfolio
8.6.5 Teva Pharmaceutical Recent Developments
8.7 Nitto Denko
8.7.1 Nitto Denko Comapny Information
8.7.2 Nitto Denko Business Overview
8.7.3 Nitto Denko Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Nitto Denko Transdermal Drug Patches Product Portfolio
8.7.5 Nitto Denko Recent Developments
8.8 Grünenthal
8.8.1 Grünenthal Comapny Information
8.8.2 Grünenthal Business Overview
8.8.3 Grünenthal Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Grünenthal Transdermal Drug Patches Product Portfolio
8.8.5 Grünenthal Recent Developments
8.9 IBSA Group
8.9.1 IBSA Group Comapny Information
8.9.2 IBSA Group Business Overview
8.9.3 IBSA Group Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 IBSA Group Transdermal Drug Patches Product Portfolio
8.9.5 IBSA Group Recent Developments
8.10 GSK
8.10.1 GSK Comapny Information
8.10.2 GSK Business Overview
8.10.3 GSK Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 GSK Transdermal Drug Patches Product Portfolio
8.10.5 GSK Recent Developments
8.11 Luye Pharma Group
8.11.1 Luye Pharma Group Comapny Information
8.11.2 Luye Pharma Group Business Overview
8.11.3 Luye Pharma Group Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Luye Pharma Group Transdermal Drug Patches Product Portfolio
8.11.5 Luye Pharma Group Recent Developments
8.12 Pfizer
8.12.1 Pfizer Comapny Information
8.12.2 Pfizer Business Overview
8.12.3 Pfizer Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Pfizer Transdermal Drug Patches Product Portfolio
8.12.5 Pfizer Recent Developments
8.13 Chattem
8.13.1 Chattem Comapny Information
8.13.2 Chattem Business Overview
8.13.3 Chattem Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Chattem Transdermal Drug Patches Product Portfolio
8.13.5 Chattem Recent Developments
8.14 Dr Reddy’s Laboratories
8.14.1 Dr Reddy’s Laboratories Comapny Information
8.14.2 Dr Reddy’s Laboratories Business Overview
8.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Portfolio
8.14.5 Dr Reddy’s Laboratories Recent Developments
8.15 Bayer
8.15.1 Bayer Comapny Information
8.15.2 Bayer Business Overview
8.15.3 Bayer Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Bayer Transdermal Drug Patches Product Portfolio
8.15.5 Bayer Recent Developments
8.16 Mundipharma
8.16.1 Mundipharma Comapny Information
8.16.2 Mundipharma Business Overview
8.16.3 Mundipharma Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 Mundipharma Transdermal Drug Patches Product Portfolio
8.16.5 Mundipharma Recent Developments
8.17 Endo International
8.17.1 Endo International Comapny Information
8.17.2 Endo International Business Overview
8.17.3 Endo International Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 Endo International Transdermal Drug Patches Product Portfolio
8.17.5 Endo International Recent Developments
8.18 Beijing Tide Pharmaceutical
8.18.1 Beijing Tide Pharmaceutical Comapny Information
8.18.2 Beijing Tide Pharmaceutical Business Overview
8.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Portfolio
8.18.5 Beijing Tide Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Transdermal Drug Patches Value Chain Analysis
9.1.1 Transdermal Drug Patches Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Transdermal Drug Patches Production Mode & Process
9.2 Transdermal Drug Patches Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Transdermal Drug Patches Distributors
9.2.3 Transdermal Drug Patches Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings